Klimek, Ludger
Brehler, Randolf
Casper, Ingrid
Klimek, Felix
Hagemann, Jan
Cuevas, Mandy
Bergmann, Karl-Christian
Funding for this research was provided by:
Charité - Universitätsmedizin Berlin
Article History
Received: 10 November 2022
Accepted: 6 December 2022
First Online: 31 January 2023
Conflict of interest
: L. Klimek reports grants and/or honoraria from Allergopharma, MEDA/Mylan, HAL Allergie, ALK Abelló, LETI Pharma, Stallergenes, Quintiles, Sanofi, grants from ASIT Biotech, Lofarma, Allergy Therapeutics, AstraZeneca, GSK, Inmunotk, Cassella med, outside the submitted work; and memberships with: AeDA, DGHNO, German Academy of Allergology and Clinical Immunology, ENT-BV, GPA and EAACI. R. Brehler reports honoraria from ALK, Allergopharma, Bencard, HAL, Leti, Stallergenes, Astra Zeneca, GSK, MedUpdate, Novertis, BiotechTools, Genentech and Circassia, outside the submitted work. M. Cuevas received personal fees and/or nonfinancial support from Novartis, Sanovi-Aventis, Allergopharma, HAL Allergie, Leti Pharma, AstraZeneca, GlaxoSmithKline, ALK Abelló, Bencard Allergie, Stallergenes, and Roxall outside of the submitted work and membership in the following organizations: AeDA, DGHNO. K.-C. Bergmann has received honoraria from Allergopharma, HAL Allergie, ALK Abelló, LETI Pharma, Stallergenes, Sanofi, Lofarma, Novartis, Bencard Allergy Therapeut., AstraZeneca and GSK in the last two years, outside the submitted work. I. Casper, F. Klimek and J. Hagemann declare that they have no competing interests.